Production (Stage)
MedMira Inc.
MIR.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -35.60% | -33.36% | -17.45% | -5.53% | -28.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -35.60% | -33.36% | -17.45% | -5.53% | -28.33% |
| Cost of Revenue | -0.80% | 4.04% | 12.76% | 17.24% | -0.28% |
| Gross Profit | -23.59% | -34.19% | -40.50% | -39.88% | -37.50% |
| SG&A Expenses | 50.27% | 28.48% | 30.32% | 40.72% | 14.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.70% | 46.84% | 35.83% | 24.05% | 2.81% |
| Operating Income | -68.38% | -61.78% | -47.01% | -30.63% | -11.40% |
| Income Before Tax | -44.96% | -48.88% | -34.70% | -22.48% | -41.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -44.96% | -48.88% | -34.70% | -22.48% | -41.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.96% | -48.88% | -34.70% | -22.48% | -41.24% |
| EBIT | -68.38% | -61.78% | -47.01% | -30.63% | -11.40% |
| EBITDA | -71.01% | -64.71% | -49.60% | -32.94% | -12.10% |
| EPS Basic | -50.00% | -53.33% | -37.93% | -21.43% | -39.13% |
| Normalized Basic EPS | -50.00% | -52.63% | -38.89% | -29.41% | -42.86% |
| EPS Diluted | -42.11% | -40.54% | -21.62% | -2.70% | -26.67% |
| Normalized Diluted EPS | -50.00% | -52.63% | -38.89% | -29.41% | -42.86% |
| Average Basic Shares Outstanding | 0.44% | 0.59% | 0.48% | 0.33% | 0.18% |
| Average Diluted Shares Outstanding | 0.44% | 0.59% | 0.48% | 0.33% | 0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |